+All News

Pharmac is defending its process for switching from branded to generic medicines in the face of a petition calling for a public inquiry into the agency’s generic medication patient safety protocols 

Dr James Polston has been announced as Scientific Director at Helius Therapeutics, leaving the United States where he was a leader of research and development at the world’s largest medicinal cannabis company, by revenue

Northland pharmacists have until 30 April to have their say on the DHB document that will govern how pharmacy services are contracted and paid for in their region over the next seven years

A resthome on Auckland’s North Shore twice provided an elderly resident with the wrong medication, in breach of her rights 

European Union-manufactured products are causing most concern for pharmacists and patients

Kaikoura Pharmacy owner David McKee has spent many years feeling frustrated and annoyed over what he sees as potentially unsafe sales of the motion sickness medicine Sea-Legs (meclozine)

The date for the reclassification of codeine coming into force will not be 31 January 2020, Medsafe group manager Chris James says

The industry body representing medicines manufacturers is concerned a lack of clarity around the upcoming codeine-containing medicines reclassification may result in a situation like the recent dextromethorphan-containing medicines “shambles”

A case involving dozens of pharmacists in the upper North Island dispensing an illegal prescription for popular painkiller tramadol and the antibiotic, metronidazole, has prominent pharmacists calling for more rapid uptake of electronic prescribing

The prospect of medicinal cannabis products being sold on pharmacy shelves may become a reality as early as next year, following last year’s passing of the Misuse of Drugs (Medicinal Cannabis) Amendment Act.